Back to results
Not yet recruitingPhase 3

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

NCT07667803

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Birmingham, Alabama, United States

+131 additional locations

Contact

AstraZeneca Clinical Study Information Center

1-877-240-9479information.center@astrazeneca.com
View on ClinicalTrials.gov